Cargando…
Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
OBJECTIVE—The purpose of this study was to evaluate the 2-year pulmonary safety of inhaled human insulin (Exubera [EXU]) in 635 nonsmoking adults with type 2 diabetes. RESEARCH DESIGN AND METHODS—Patients were randomly assigned to receive prandial EXU or subcutaneous insulin (regular or short-acting...
Autores principales: | Rosenstock, Julio, Cefalu, William T., Hollander, Priscilla A., Belanger, Andre, Eliaschewitz, Freddy G., Gross, Jorge L., Klioze, Solomon S., St. Aubin, Lisa B., Foyt, Howard, Ogawa, Masayo, Duggan, William T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518332/ https://www.ncbi.nlm.nih.gov/pubmed/18535196 http://dx.doi.org/10.2337/dc08-0159 |
Ejemplares similares
-
Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension
por: Cefalu, William T., et al.
Publicado: (2015) -
Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)
por: Gatto, Nicolle M., et al.
Publicado: (2019) -
Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists
por: Cahn, Avivit, et al.
Publicado: (2015) -
Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
por: Bergenstal, Richard M., et al.
Publicado: (2008) -
Inhaled human insulin (Exubera®): clinical profile and patient considerations
por: Barnett, Anthony H, et al.
Publicado: (2007)